84 related articles for article (PubMed ID: 21875223)
1. Effects of acute nicotine administration on resting EEG in nonsmokers.
Fisher DJ; Daniels R; Jaworska N; Knobelsdorf A; Knott VJ
Exp Clin Psychopharmacol; 2012 Feb; 20(1):71-5. PubMed ID: 21875223
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
Knott VJ; Fisher DJ
Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
[TBL] [Abstract][Full Text] [Related]
3. Clonidine pre-treatment fails to block acute smoking-induced EEG arousal/mood in cigarette smokers.
Knott VJ; Raegele M; Fisher D; Robertson N; Millar A; McIntosh J; Ilivitsky V
Pharmacol Biochem Behav; 2005 Jan; 80(1):161-71. PubMed ID: 15652392
[TBL] [Abstract][Full Text] [Related]
4. Nicotine-induced cortical activation among nonsmokers with moderation by trait cognitive control.
Sutton SK; Van Rensburg KJ; Jentink KG; Drobes DJ; Evans DE
Psychopharmacology (Berl); 2016 Jun; 233(12):2301-8. PubMed ID: 27044353
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular, electrocortical, and behavioral effects of nicotine chewing gum.
Michel C; Hasenfratz M; Nil R; Bättig K
Klin Wochenschr; 1988; 66 Suppl 11():72-9. PubMed ID: 3184782
[TBL] [Abstract][Full Text] [Related]
6. Effects of nicotine on electroencephalographic (EEG) and behavioural measures of visual working memory in non-smokers during a dual-task paradigm.
Fisher DJ; Knobelsdorf A; Jaworska N; Daniels R; Knott VJ
Pharmacol Biochem Behav; 2013 Jan; 103(3):494-500. PubMed ID: 23026057
[TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
Poltavski DV; Petros T
Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
[TBL] [Abstract][Full Text] [Related]
8. Neural effects of nicotine during auditory selective attention in smokers: an event-related potential study.
Knott V; Blais C; Scherling C; Camarda J; Millar A; Fisher D; McIntosh J
Neuropsychobiology; 2006; 53(3):115-26. PubMed ID: 16601362
[TBL] [Abstract][Full Text] [Related]
9. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
10. Caffeine and opening the eyes have additive effects on resting arousal measures.
Barry RJ; Clarke AR; Johnstone SJ
Clin Neurophysiol; 2011 Oct; 122(10):2010-5. PubMed ID: 21489866
[TBL] [Abstract][Full Text] [Related]
11. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.
Cole DM; Beckmann CF; Long CJ; Matthews PM; Durcan MJ; Beaver JD
Neuroimage; 2010 Aug; 52(2):590-9. PubMed ID: 20441798
[TBL] [Abstract][Full Text] [Related]
12. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity.
Ettinger U; Williams SC; Patel D; Michel TM; Nwaigwe A; Caceres A; Mehta MA; Anilkumar AP; Kumari V
Neuroimage; 2009 Apr; 45(2):549-61. PubMed ID: 19159693
[TBL] [Abstract][Full Text] [Related]
14. Nicotine enhances automatic temporal processing as measured by the mismatch negativity waveform.
Martin LF; Davalos DB; Kisley MA
Nicotine Tob Res; 2009 Jun; 11(6):698-706. PubMed ID: 19436039
[TBL] [Abstract][Full Text] [Related]
15. The moderating influence of nicotine and smoking on resting-state mood and EEG changes in remitted depressed patients during tryptophan depletion.
Knott V; Bisserbe JC; Shah D; Thompson A; Bowers H; Blais C; Ilivitsky V
Biol Psychol; 2013 Dec; 94(3):545-55. PubMed ID: 24056129
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
[TBL] [Abstract][Full Text] [Related]
18. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute nicotine administration on behavioral and neural (EEG) correlates of working memory in non-smokers.
Fisher DJ; Daniels R; Jaworska N; Knobelsdorf A; Knott VJ
Brain Res; 2012 Jan; 1429():72-81. PubMed ID: 22079316
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.
Gehricke JG; Hong N; Whalen CK; Steinhoff K; Wigal TL
Psychol Addict Behav; 2009 Dec; 23(4):644-55. PubMed ID: 20025370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
